The present invention relates to novel amphiphilic dendrimers, hereafter denoted Dendri-TAC. The present invention also relates to perfluorocarbon nanoemulsions stabilized by these amphiphilic dendrimers and their uses for in vivo diagnostic and/or for therapy, notably as theranostic tools, for detection and/or treatment of cancer.
Desgranges, Stéphane, Wlodzimierz Urbach, Lucie Somaglino, Nicolas Taulier, and Christiane Pepin. "Dendri-tac and their use as theranostics." U.S. Patent Application 15/571,528, filed May 10, 2018.
View full article